58546-21-7|Agavoside H|Agavoside H|-范德生物科技公司

Agavoside H

NMR下载 COA and HPLC MSDS下载
names：
Agavoside H
CAS号：
58546-21-7
MDL Number：
MF(分子式)： C68H112O37 MW(分子量)： 1521.61
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Furostan-12-one, 3-((O-6-deoxy-alpha-L-mannopyranosyl-(1-4)-O-6-deoxy-alpha-L-mannopyranosyl-(1-3)-O-(beta-D-xylopyranosyl-(1-2))-O-beta-D-glucopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-4)-beta-D-galactopyranosyl)oxy)-26-(beta-D-glucopyranosyloxy)-22-hydroxy-, (3-beta,5-alpha,22-alpha,25R)-
英文别名	Agavoside H;
CAS号	58546-21-7
SMILES	CC1C2C(OC1(O)CCC(COC3C(O)C(O)C(O)C(CO)O3)C)CC4C2(C)C(CC5C4CCC6C5(C)CCC(OC7C(O)C(O)C(OC8C(O)C(O)C(OC9C(OC%10C(O)C(OC%11C(O)C(O)C(O)C(C)O%11)C(O)C(C)O%10)C(OC%12C(O)C(O)C(O)CO%12)C(O)C(CO)O9)C(CO)O8)C(CO)O7)C6)=O
Inchi	InChI=1S/C68H112O37/c1-22(20-91-59-49(85)45(81)42(78)33(16-69)96-59)9-12-68(90)23(2)38-32(105-68)14-30-28-8-7-26-13-27(10-11-66(26,5)29(28)15-37(74)67(30,38)6)95-62-51(87)46(82)54(35(18-71)98-62)100-63-52(88)47(83)55(36(19-72)99-63)101-65-58(57(43(79)34(17-70)97-65)103-60-48(84)41(77)31(73)21-92-60)104-64-53(89)56(40(76)25(4)94-64)102-61-50(86)44(80)39(75)24(3)93-61/h22-36,38-65,69-73,75-90H,7-21H2,1-6H3
InchiKey	UUFUBRZQDOOECH-UHFFFAOYSA-N
分子式 Formula	C68H112O37
分子量 Molecular Weight	1521.61
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Agavoside H(CAS:58546-21-7):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Agavoside H is biochemical.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Calabrese JR, Jin N, Johnson B, Such P, Baker RA, Madera J, Hertel P, Ottinger J, Amatniek J, Kawasaki H. Aripiprazole once-monthly as maintenance treatment for bipolar I disorder: a 52-week, multicenter, open-label study. Int J Bipolar Disord. 2018 Jun 10;6(1):14. doi: 10.1186/s40345-018-0122-z. PubMed PMID: 29886522.

[2]Guevara-Luna J, Alvarez-Fitz P, Ríos-Leal E, Acevedo-Quiroz M, Encarnación-Guevara S, Moreno-Godinez ME, Castellanos-Escamilla M, Toribio-Jiménez J, Romero-Ramírez Y. Biotransformation of benzo[a]pyrene by the thermophilic bacterium Bacillus licheniformis M2-7. World J Microbiol Biotechnol. 2018 Jun 9;34(7):88. doi: 10.1007/s11274-018-2469-9. PubMed PMID: 29886516.

[3] Pomarè Montin D, Ankawi G, Lorenzin A, Neri M, Caprara C, Ronco C. Biocompatibility and Cytotoxic Evaluation of New Sorbent Cartridges for Blood Hemoperfusion. Blood Purif. 2018 Jun 8;46(3):187-195. doi: 10.1159/000489921. [Epub ahead of print] PubMed PMID: 29886501.

[4] Villa G, Neri M, De Rosa S, Samoni S, Chelazzi C, Romagnoli S, Lorenzin A, de Cal M, Ronco C, De Gaudio AR. Albumin Loss and Citrate Load in Pre-Dilution High Cut-Off-CVVHDF with Regional Citrate (18 mmol/L) and High Cut-Off CVVHD with Systemic Heparin: An in vitro Study. Blood Purif. 2018 Jun 8;46(3):205-213. doi: 10.1159/000490342. [Epub ahead of print] PubMed PMID: 29886476.

[5] Tan W, Wang W, Zheng X, Chen J, Yuan X, Zhang F, Wang S, Tao L. [Effect of fluorofenidone on renal interstitial fibrosis in rats with unilateral ureteral obstruction]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 May 28;43(5):511-519. doi: 10.11817/j.issn.1672-7347.2018.05.009. Chinese. PubMed PMID: 29886467.

6: Kojima YA, Wang X, Sun H, Compton F, Covinsky M, Zhang S. Reproducible evaluation of tumor-infiltrating lymphocytes (TILs) using the recommendations of International TILs Working Group 2014. Ann Diagn Pathol. 2018 May 31;3

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开